SURVIVAL OUTCOMES OF AUTOLOGOUS STEM CELL TRANSPLANTATION IN LYMPHOMA PATIENTS

SURVIVAL OUTCOMES OF AUTOLOGOUS STEM CELL TRANSPLANTATION IN LYMPHOMA PATIENTS

Objective: Lymphomas, a diverse group of hematological malignancies, vary significantly in their prognosis, survival outcomes and response to treatment. High-dose chemotherapy followed by autologous stem cell transplantation (ASCT) has been frequently used to treat patients with relapsed or refracto...

Full description

Saved in:

Bibliographic Details
Main Authors:	Elif Yıldız, Güven Çetin, Özge Pasin
Format:	Article
Language:	English
Published:	Elsevier 2024-12-01
Series:	Hematology, Transfusion and Cell Therapy
Online Access:	http://www.sciencedirect.com/science/article/pii/S2531137924028554
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

AUTOLOGOUS STEM CELL TRANSPLANTATION FOR AGGRESSIVE LYMPHOMAS
by: Giuseppe Visani, et al.
Published: (2012-11-01)

Impact of Autologous and Allogeneic Stem Cell Transplantation in Peripheral T-Cell Lymphomas
by: Peter Reimer
Published: (2010-01-01)

UPDATE ON THE ROLE OF AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANT IN FOLLICULAR LYMPHOMAS
by: Mónica Cabrero, et al.
Published: (2012-01-01)

Influence of applied CD34+ cell dose on the survival of Hodgkin's lymphoma and multiple myeloma patients following autologous stem cell transplants
by: Todorović-Balint Milena, et al.
Published: (2020-01-01)

The Role of Autologous Stem Cell Transplantation in the Treatment of Diffuse Large B-Cell Lymphoma
by: Marco Gunnellini, et al.
Published: (2012-01-01)

ADULT T-CELL LEUKEMIA/LYMPHOMA RELAPSED AFTER AUTOLOGOUS TRANSPLANT AND TREATED WITH HAPLOIDENTICAL STEM CELL TRANSPLANT
by: TFN Araújo, et al.
Published: (2024-10-01)

Quality of life before autologous stem cells transplantation as prognostic factor in patients with malignant lymphomas
by: Yu. L. Shevchenko, et al.
Published: (2014-07-01)

Hodgkin’s Lymphoma after Autologous Stem-Cell Transplantation: Effective Consolidation with Brentuximab Vedotin
by: Adrian Schmidt
Published: (2020-11-01)

THE ROLE OF AUTOLOGOUS AND ALLOGENEIC STEM CELL TRANSPLANTATION IN FOLLICULAR LYMPHOMA IN THE NEW DRUGS ERA.
by: Francesco Maura, et al.
Published: (2016-09-01)

Evaluation of outcome and safety profile in high-dose BEAM and Benda-EAM chemotherapy with subsequent autologous stem cell transplantation in lymphoma patients
by: Kinga Krawiec, et al.
Published: (2024-07-01)

The experience of relapsed Burkitt lymphoma treatment with targeted drugs and autologous/allogeneic stem cell transplantation
by: T. T. Valiev, et al.
Published: (2024-01-01)

PROGNOSTIC SIGNIFICANCE OF POSITRON EMISSION TOMOGRAPHY IN AUTOLOGOUS STEM CELL TRANSPLANTATION FOR NON-HODGKIN’S LYMPHOMA
by: V. G. Potapenko, et al.
Published: (2017-01-01)

Role of Positron-Emission Tomography in Prognosis of Outcomes of High-Dose Chemotherapy with Autologous Hematopoietic Stem Cell Transplantation in Hodgkin’s Lymphoma
by: VG Potapenko, et al.
Published: (2016-10-01)

Evaluating the safety and feasibility of allogeneic NK cell infusion in high-risk lymphoma patients post-autologous stem cell transplantation
by: Shirin Tavakoli, et al.
Published: (2025-05-01)

Insomnia in patients undergoing Autologous Hematopoietic Stem Cell Transplantation
by: Mayra Veronese, et al.
Published: (2024-06-01)

Long-Term Outcome after Autologous Stem Cell Transplantation with Adequate Peripheral Blood Stem Cell Mobilization Using Plerixafor and G-CSF in Poor Mobilizer Lymphoma and Myeloma Patients
by: Jan S. Moreb, et al.
Published: (2011-01-01)

Cryopreservation of Hematopoietic Stem Cells for Pediatric Autologous Stem Cell Transplantation
by: Rasika Dhawan Setia, et al.
Published: (2024-11-01)

Real World Predictors, Timing, and Outcomes of Autologous Stem Cell Transplantation in Patients with Multiple Myeloma
by: Lisa Blackburn, et al.
Published: (2024-10-01)

AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION IN HODGKIN'S LYMPHOMA: PRELIMINARY RESULTS IN A PRIVATE HOSPITAL IN NORTHEAST BRAZIL
by: ES Eulalio, et al.
Published: (2024-10-01)

Reduction in incidence of early fatal complications of high-dose chemotherapy with autologous hematopoietic stem cell transplantation in Hodgkin lymphoma patients
by: N. V. Zhukov, et al.
Published: (2014-07-01)

Outcomes of Allogeneic Stem Cell Transplant in Patients with Relapsed/Refractory Hodgkin Lymphoma
by: Shiliang Ge, et al.
Published: (2025-02-01)

Autologous stem cell transplantation in the treatment of Hodgkin's disease
by: Tarabar Olivera, et al.
Published: (2009-01-01)

Autologous hematopoietic stem cell transplantation for systemic scleroderma
by: R T Alekperov, et al.
Published: (2012-08-01)

OUTCOME OF PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA RELAPSING AFTER AUTOLOGOUS TRANSPLANT BEFORE AVAILABILITY OF CAR-T CELL TREATMENT
by: Ulrike Bacher, et al.
Published: (2023-04-01)

Autologous stem cell transplantation for relapsed/refractory large B-cell lymphoma: a multicenter GETH-TC/GELTAMO study
by: Leyre Bento, et al.
Published: (2025-07-01)

DETERMINATION OF FREQUENCY AND RISK FACTORS OF SECONDARY MALIGNANCY DEVELOPMENT IN HEMATOLOGICAL MALIGNANCIES
by: Ennur Ramadan, et al.
Published: (2024-12-01)

Long-Term Outcomes in Patients with Plasma Cell Myeloma Following High-Dose Chemotherapy with Autologous Stem Cell Transplantation
by: Eva Oehlbaum, et al.
Published: (2022-10-01)

Clinical outcomes of chimeric antigen receptor T-cell therapy following autologous hematopoietic stem cell transplantation in 38 patients with refractory/relapsed primary or secondary central nervous system lymphoma
by: Jiaying Wu, et al.
Published: (2024-11-01)

Time to progression predicts outcome of patients with multiple myeloma that can be influenced by autologous hematopoietic stem cell transplantation
by: Yanhua Yue, et al.
Published: (2025-12-01)

Therapeutic Potential of Autologous Stem Cell Transplantation for Cerebral Palsy
by: Chaitanya Purandare, et al.
Published: (2012-01-01)

AUTOLOGOUS STEM CELL TRANSPLANTATION IN ELDERLY ACUTE MYELOID LEUKEMIA
by: Gert J. Ossenkoppele, et al.
Published: (2013-02-01)

Treatment of refractory ulcers of the rectum by autologous stem-cell transplantation
by: S. F. Bagnenko, et al.
Published: (2024-11-01)

Certain Aspects of Autologous Hematopoietic Stem Cell Transplantation in Patients with Multiple Myeloma
by: SV Gritsaev, et al.
Published: (2017-01-01)

Pharmacokinetics and outcome of high-dose melphalan followed by autologous stem cell transplantation in dialysis-dependent patients with multiple myeloma
by: Rabea Mecklenbrauck, et al.
Published: (2025-01-01)

Optimizing Autologous Stem Cell Transplantation in Multiple Myeloma: The Significance of Pre-Transplant Controlling Nutritional Status Score
by: Sıdıka Gülkan Özkan, et al.
Published: (2025-02-01)

Acute kidney injury in autologous hematopoietic stem cell transplant for patients with lymphoma – KDIGO classification with creatinine and urinary output criteria: a cohort analysis
by: Natacha Rodrigues, et al.
Published: (2023-12-01)

Biomarker Identification in Patients with Multiple Sclerosis Treated with Autologous Hematopoietic Stem Cell Transplantation
by: Moisés Manuel Gallardo-Pérez, et al.
Published: (2025-03-01)

The use of non-cryopreserved hematopoietic stem cells for autologous transplantation in multiple myeloma patients
by: S. V. Voloshin, et al.
Published: (2022-04-01)

UPDATE ON THE ROLE OF AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION IN MULTIPLE MYELOMA
by: Patrizia Tosi, et al.
Published: (2012-01-01)

The Progress of Autologous Hematopoietic Stem Cell Transplantation in the Treatment of Multiple Myeloma
by: Ya-Nan Wang MS, et al.
Published: (2025-03-01)